[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336778-105":59,"doc-detail-336778-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","association-of-cancer-with-heart-failure-and-the-prognostic-value-of-nt-probnp-in-cancer-patients-findings-from-the-nhanes-19992018","Association of Cancer with Heart Failure and the Prognostic Value of NT-proBNP in Cancer Patients - Findings from the NHANES (1999–2018)","","Evidence regarding the association between cancer and heart failure (HF) is scarce. This cohort study investigates the relationship between HF and cancer and evaluates the prognostic value of NT-proBNP in cancer patients. Using NHANES data from 1999 to 2018 with mortality follow-up through 2019, the study included 54,847 adults with valid self-reported cancer and HF status. Multivariable logistic regression, Kaplan–Meier survival analyses, and propensity score matching showed HF and cancer were mutually associated and that elevated NT-proBNP predicted shorter survival.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/association-of-cancer-with-heart-failure-and-the-prognostic-value-of-nt-probnp-in-cancer-patients-findings-from-the-nhanes-19992018/336778/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/association-of-cancer-with-heart-failure-and-the-prognostic-value-of-nt-probnp-in-cancer-patients-findings-from-the-nhanes-19992018/336778.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research question of the study?","Question",{"text":112,"@type":113},"The study examines whether heart failure is associated with cancer and whether NT-proBNP has prognostic value in cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were outcomes and associations analyzed?",{"text":117,"@type":113},"The study used NHANES data with mortality linkage, multivariable logistic regression for odds ratios, propensity score matching, and Kaplan–Meier survival analysis with log-rank tests.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about the relationship between HF and cancer?",{"text":121,"@type":113},"After propensity score matching, HF was associated with a higher occurrence of cancer, and cancer was associated with a higher occurrence of HF. Patients with both conditions showed the shortest survival over 10 years.",{"name":123,"@type":110,"acceptedAnswer":124},"How does NT-proBNP relate to prognosis in cancer patients without known HF?",{"text":125,"@type":113},"In cancer patients without HF, NT-proBNP levels higher than 51.51 pg/mL were associated with shorter survival, based on Kaplan–Meier and log-rank results.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},336778,1790399297,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Article  \nAssociation of Cancer with Heart Failure and the Prognostic Value of NT-proBNP in Cancer Patients: Findings from the NHANES (1999–2018)  \nQingping Zeng 1,2,†, Weihong Chang 1,2,†, Rui Zhang 1,2, Hongxuan Fan 1,2, Zixuan Dou 3, Aman Liu 1,2, Jie Yu 4,5, * and Boda Zhou 2, *  \nCitation: Zeng, Q.; Chang, W.; Zhang, R.; Fan, H.; Dou, Z.; Liu, A.; Yu, J.; Zhou, B. Association of Cancer with Heart Failure and the Prognostic Value of NT-proBNP in Cancer Patients: Findings from the NHANES (1999–2018) . Curr. Oncol. 2024, 31, 4927–4939. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)curroncol31090365  \nReceived: 20 July 2024  \nRevised: 18 August 2024  \nAccepted: 24 August 2024  \nPublished: 26 August 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 School of Clinical Medicine, Tsinghua University, Beijing 102218, China  \n2 Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China  \n3 School of Medicine, Tsinghua University, Beijing 100084, China  \n4 Cardiovascular Department, John Hunter Hospital, Newcastle, NSW 2305, Australia  \n5 The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, NSW 2000, Australia  \n* [Correspondence: jie.yu@health.nsw.gov.au](Correspondence: jie.yu@health.nsw.gov.au) (J.Y.); [zhouboda@tsinghua.edu.cn](zhouboda@tsinghua.edu.cn) (B.Z.)† These authors contributed equally to this work.  \nAbstract: Evidence regarding the association between cancer and heart failure (HF) is scarce. This study is to investigate the association between HF and cancer and explore the prognostic value of NTproBNP in cancer patients. This cohort study used National Health and Nutrition Examination Survey data from 1999 to 2018 and linked mortality information until 2019 . We included all participants with valid answer to questions regarding self-reported cancer and HF. Multivariable logistic regression was used to estimate odds ratios (ORs) and 95% CIs. Our study included data from 54,847 adult participants. During a median (IQR) follow-up of 9.6 (4.0–15.1) years, 7674 deaths were recorded. HF was associated with an increased occurrence of cancer after propensity score matching (OR = 1.46, 95% CI: 1.17–1.82, p \u003C 0.001) . Cancer was associated with a higher occurrence of HF (OR = 1.33, 95% CI: 1.11–1.59, p = 0.002) . Kaplan–Meier survival analysis over 10 years revealed the shortest survival in patients with both HF and cancer (log-rank p \u003C 0.0001) . Importantly, NT-proBNP was significantly higher in cancer patients, no matter whether with known HF (p \u003C 0.01) . In cancer patients without HF, NT-proBNP higher than 51.51 pg/mL was associated with shorter survival (log-rank p \u003C 0.0001) . Findings from this cohort study suggest that HF is significantly associated with cancer. NT-proBNP was higher in cancer patients, with significant prognostic value in cancer patients.  \nKeywords: heart failure; cancer; survival; NT-proBNP  \n1. Introduction  \nThe number of newly diagnosed cancers has soared from 18.7 million in 2010 to 23.6 million in 2019, with an increase of 26.3% . At the same time, the global death from cancer rose from 8 .29 million to 10 million, an increase of 20 .9% in the last decade [1] . Compared to these cancer statistics, the global burden of HF ranges from 1–3% in the general adult population, from 1 to 20 cases per 1000 people, with a five-year mortality rate of 50 to 75%[2] . In clinical practice, we observed that cancer patients are prone to suffering from HF. In 2013, Tal Hasin and his team conducted the first in-depth study of the association betwee","cbCail0Zud9QQjR4","https://ap.wps.com/l/cbCail0Zud9QQjR4","pdf",1500694,13,"English","# Introduction\n## Cancer and heart failure burden\n## Evidence gaps on bidirectional association\n# Methods\n## Study design and data source (NHANES 1999–2018)\n## Definitions and participant inclusion\n## Statistical analyses (logistic regression, matching, survival models)","[{\"question\":\"What is the main research question of the study?\",\"answer\":\"The study examines whether heart failure is associated with cancer and whether NT-proBNP has prognostic value in cancer patients.\"},{\"question\":\"How were outcomes and associations analyzed?\",\"answer\":\"The study used NHANES data with mortality linkage, multivariable logistic regression for odds ratios, propensity score matching, and Kaplan–Meier survival analysis with log-rank tests.\"},{\"question\":\"What did the study find about the relationship between HF and cancer?\",\"answer\":\"After propensity score matching, HF was associated with a higher occurrence of cancer, and cancer was associated with a higher occurrence of HF. Patients with both conditions showed the shortest survival over 10 years.\"},{\"question\":\"How does NT-proBNP relate to prognosis in cancer patients without known HF?\",\"answer\":\"In cancer patients without HF, NT-proBNP levels higher than 51.51 pg/mL were associated with shorter survival, based on Kaplan–Meier and log-rank results.\"}]","Association of Cancer with Heart Failure and the Prognostic Value of NT-proBNP in Cancer Patients - Findings from the NHANES (1999–2018) | PDF",1790016582,33,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01b38e17d13783288f4c06b3406d8dfb.webp",983,1390,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20648136b636251d8f39770d69e23d80.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/513fcff8cd0ad2fc9c2154ce7a0abefc.webp",981,1387,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27a4f076543d2c5ba5f5738316db5980.webp",980,1385]